Akèy › Ipertiwoïdism › Texas
Etid klinik pou Ipertiwoïdism nan Texas
6 etid pou Ipertiwoïdism ap chèche patisipan nan sit nan Texas.
Vil nan Texas
Tèks ofisyèl etid la (Anglè)
Study to Determine if BHV-1300 is Effective and Safe in Adults With Graves' Disease
- Site-081, Amarillo
- Site-055, Dallas
- Site-020, Dallas
- ak 8 plis
Ap rekriteFaz 3
Laj 18 a 70 · Tout sèks · Mizajou Oct 1, 2026 · NCT07661056NEXUS Study: A Study to Test Single and Multiple Doses of MER511 Given to Adults With Graves' Disease
- Site # 1113, DeSoto
- Site # 1105, Webster
Ap rekriteFaz 1
Laj 18 a 65 · Tout sèks · Mizajou Sep 30, 2026 · NCT07305818A Study to Learn About The Effects of Felzartamab on Thyroid Function and Its Safety in Adults With Graves' Disease Ages 18 to 75 Years Old
- M3 Wake Research - Dallas, Dallas
Ap rekriteFaz 2
Laj 18 a 75 · Tout sèks · Mizajou Sep 4, 2026 · NCT07722546Evaluation of YB-101 for Safety, Tolerability, Pharmacokinetics, and Efficacy in Graves' Disease
- Site 100, Amarillo
- Site 117, Conroe
- Clinical Research Site, Dallas
- ak 6 plis
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Sep 4, 2026 · NCT07682896A Study to Assess the Efficacy, Safety, and Tolerability of IMVT-1402 as Treatment for Adult Participants With Graves' Disease
- Site Number - 1002, Austin
- Site Number - 1067, Bellaire
- Site Number - 1019, Dallas
- ak 5 plis
Ap rekriteFaz 2
Laj 18 a 75 · Tout sèks · Mizajou Aug 25, 2026 · NCT06727604Study of BHV-1300 in Graves' Disease
- Site-109, Dallas
- Site-106, Houston
- Site-101, Houston
- ak 1 plis
Ap rekriteFaz 1
Laj 18 a 65 · Tout sèks · Mizajou Jul 31, 2026 · NCT06980649Sous ClinicalTrials.gov, done yo ranmase Oct 2, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.